FDA Recall Terminated

Abbott Clinical Chemistry Creatine Kinase, Model LN 7D63-30, Lot Number: 52044HW00; Expires October 19, 2007, RCR#2018433-10/25/07-006R Abbott Laboratories, Inc., South Pasadena CA 91030

Recall: Z-1109-2008 · Initiated October 12, 2007

Recall

Recall Number
Z-1109-2008
Event Number
46387
Firm
Abbott Laboratories Inc.
FEI Number
2018433
Product Code
CGS
Status
Terminated
Root Cause
Nonconforming Material/Component
Initiated
October 12, 2007
Posted
March 19, 2008
Terminated
March 28, 2012
Address
820 Mission St, South Pasadena, CA, 91030-3142

Description

Abbott Clinical Chemistry Creatine Kinase, Model LN 7D63-30, Lot Number: 52044HW00; Expires October 19, 2007, RCR#2018433-10/25/07-006R Abbott Laboratories, Inc., South Pasadena CA 91030

Reason

Three potential issues with Creatine Kinase Lot Number: 52044HW00: (1) Decrease in quality control and/or patient results (2) An iIncreased imprecision, or (3) Error Code 1054 (Unable to calculate results, Reaction Failure) on Architect cSystems.

Action

On October 12, 2007, A Product Recall letter was provided to all Clinical Chemistry Creatine Kinase Reagent customers that have received lot number 52044HW00 . Customer reply form were included in all US customers letter. The letter instructed customers to discontinue use of the kits and destroy them following their laboratory procedure, and document the number of kits discarded. Abbott will provide reimbursement for destroyed kits.

Distribution

Worldwide Distribution --- including USA and countries of Canada, Chili, Uruguay, Germany, Hong Kong, and New Zealand.

Quantity

334 Distributed Worldwide; 164 Domestically